Anti-vimentin antibody treatment inhibited subcutaneous tumor xenograft growth and tumor blood vessel density in mice, suggesting that vimentin is localized to the cell surface in tumor endothelial cells [38]. The gene discussed is VIM; the disease is neoplasm.